Labcorp Holdings Inc.

LH Healthcare Diagnostics & Research

Labcorp Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.0 billion, up 7.25% from fiscal 2024.

Revenue
+6.92%
EPS
+3.18%
Free cash flow
+44.7%
Total debt
+3.21%

Quarter to September 2026, against a year earlier

362.28 5.51 −1.50%
Market cap
$29.5B
P/E
29.5×
Fwd P/E
26.7×
Dividend yield
0.79%
F-score
8/9
Altman Z
3.02
Beneish M
−2.55
Dividend safety
74/100
Older periods Dec '25 Mar '26 Jun '26 Sep '26
Piotroski F-Score

+8 more TTM periods

8 7 8 7
ROE
10.51% 11.05% 11.74% 11.45%
ROA
4.77% 5.13% 5.48% 5.40%
ROIC
6.54% 6.59% 6.50% 6.76%
Return on Tangible Assets
20.49% 18.89% 20.92% 23.41%
Average Days of Receivables
59.14 63.24 63.72 63.99
Free Cash Flow per Share
14.59 17.00 14.33 15.97
Free Cash Flow
1,214.00 1,399.30 1,170.50 1,294.90
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026